A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes "TF0023"


Phase 2 Results N/A

Summary of Purpose

This is a phase 2, multicenter, randomized, double-blind (within dose), placebo controlled, parallel-group, dose-range finding study to evaluate the efficacy and safety of TF0023 spray versus placebo in functional improvement of patients with ischemic strokes under standard of care.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 March 2018.

1 Mar 2017 5 May 2016 1 Mar 2020 1 May 2020 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment